Retina Futura
Retina Futura is a new project that will be launched during the FLORetina-ICOOR Meeting 2024, which will be held in Florence (Italy) from 5 to 8 December.
It features an informative and engaging program focused on emerging treatments and innovation in the retina field, where latest results from research and clinical trials will be presented.
It will span across two distinctive 75-minute sessions on Friday, 6 December, integrated within the official Meeting program.
As an add-on to this launch, there will be also a Clinical Trial Reception, on the same day but at 6:00pm, where biopharmaceutical companies will present their ongoing or planned clinical trials that are relevant to our global audience but specifically to the European healthcare ecosystem.
Become part of Retina Futura network!
Discover Retina Futura 2024 Agenda
Latest news
Retina Futura Late Breakers
There are only few slots still available in Retina Futura sessions: we are thus inviting you to submit an abstract if you wish to present on the latest cutting-edge research and innovative clinical approaches shaping the future of retinal care.
We welcome submissions covering a range of topics, including but not limited to:
- Novel therapies for retinal diseases
- Advances in gene therapy, cell therapy, and regenerative medicine
- Ongoing clinical trial results.
Selected abstracts will be featured in Retina Futura sessions, and authors will have the opportunity to present their work to leading experts and peers in the field.
Submission Guidelines:
- Deadline: November 10, 2024
- Please include a brief description of your research, key findings, and potential impact on clinical practice.
Submit your abstract today (click here) and be part of this exciting opportunity to contribute to the future of retinal research and care!
For more information, please visit the Congress Website or contact the Organizing Secretariat (Riccardo Iannantuoni - A.P. Meetings: riccardo.iannantuoni@apmeetings.com).
Retina Futura Clinical Trial Symposium
We are also offering the opportunity for biopharmaceutical companies to present their ongoing or planned clinical trials that are relevant to our global audience but specifically to the European healthcare ecosystem. This is a unique opportunity to showcase your groundbreaking research and developments that have not yet been introduced in Europe.
Retina Futura Clinical Trial Symposium (RFCTS) (link da Anna) has been designed to:
- Connect companies with leading experts, regulators, and stakeholders in the European and global healthcare sectors;
- Highlight innovative approaches to unmet medical needs;
- Explore potential collaborations and partnerships in the European market.
Submission deadline: November 10, 2024 - click here
We would be honored to feature your work in this exclusive forum and look forward to the opportunity of including your insights in the program!